Our results of elevated CCL17 and CCL22 levels in peripheral blood from morbidly obese patients suggest that these chemokines may play a role in leukocyte trafficking and endothelial dysfunction in obesity, in addition to their role as chemoattractants in the adipose tissue milieu (21). Here, CCL22 is linked to obesity disorder.